Scarica l'app Stockscreener
2.25
7.41%
-0.18
Clearmind Medicine Inc Borsa (CMND) Ultime notizie
Clearmind advances AUD treatment as phase I/IIa trial progresses By Investing.com - Investing.com India
Clearmind Medicine Inc. Reflects on Major Progress in 2025 Clinical Trials for CMND-100 Targeting Alcohol Use Disorder - Quiver Quantitative
Trading Recap: How strong is Clearmind Medicine Inc. stock balance sheetJuly 2025 Selloffs & Weekly Setup with ROI Potential - moha.gov.vn
How interest rate cuts could boost Clearmind Medicine Inc. stock2025 Geopolitical Influence & Short-Term High Return Ideas - Улправда
Why retail traders accumulate Clearmind Medicine Inc. (CWY0) stockJuly 2025 PostEarnings & Reliable Breakout Forecasts - Улправда
Will Clearmind Medicine Inc. stock benefit from AI adoptionJuly 2025 Chart Watch & Comprehensive Market Scan Reports - Улправда
Why Clearmind Medicine Inc. stock remains on buy listsEarnings Trend Report & AI Powered Market Trend Analysis - DonanımHaber
Published on: 2025-12-19 05:54:25 - Улправда
Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial - TipRanks
Published on: 2025-12-18 16:01:28 - Улправда
Is Clearmind Medicine Inc. stock a top momentum playJuly 2025 Summary & Community Verified Trade Signals - Улправда
Sentiment Review: How Clearmind Medicine Inc CWY0 stock reacts to monetary easingJuly 2025 Setups & Weekly High Potential Alerts - moha.gov.vn
Clearmind Medicine completes second cohort enrollment in Phase I/IIa AUD trial - TipRanks
Clearmind Medicine announces successful completion of second cohort enrollment - marketscreener.com
Clearmind completes enrollment for second AUD treatment trial cohort - Investing.com
Clearmind completes enrollment for second AUD treatment trial cohort By Investing.com - Investing.com South Africa
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100 - The Manila Times
Clearmind Medicine Inc. Announces Successful Enrollment of Second Patient Cohort in Phase I/IIa Trial for CMND-100 to Treat Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine (Nasdaq: CMND) fills 2nd CMND-100 AUD trial cohort - Stock Titan
Clearmind Medicine announces receipt of Nasdaq minimum bid price notification - MSN
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment - The Manila Times
Clearmind Medicine Regains Compliance With Nasdaq's Minimum Stockholders' Equity Requirement - marketscreener.com
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - The Manila Times
Clearmind Medicine regains compliance with Nasdaq listing rule By Investing.com - Investing.com Canada
Clearmind regains compliance with Nasdaq minimum equity rule - Investing.com
Clearmind Medicine regains compliance with Nasdaq listing rule - Investing.com
Clearmind Medicine Inc. Regains Compliance with Nasdaq Listing Rule on Minimum Stockholders’ Equity - Quiver Quantitative
Clearmind regains compliance with Nasdaq minimum equity rule By Investing.com - Investing.com UK
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum ... | Associated Press | syndication news - Enidnews.com
Clearmind Medicine To Implement 1-for-40 Reverse Stock Split Next Week - Nasdaq
Why Did Clearmind Medicine Shares Plunge 29% After Hours? - Benzinga
Clearmind Medicine to enact 1-for-40 reverse share split; shares down - MSN
Clearmind Medicine to implement 1-for-40 reverse stock split - Investing.com India
Clearmind Medicine to implement 1-for-40 reverse stock split By Investing.com - Investing.com Australia
Clearmind Medicine Inc. Announces 1-for-40 Reverse Share Split to Regain Nasdaq Compliance - Quiver Quantitative
Clearmind Medicine Announces 1-for-40 Reverse Share Split - The Manila Times
Clearmind Medicine Announces 1-for-40 Reverse Share Split | Associated Press | syndication news - Enidnews.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification - marketscreener.com
Clearmind Medicine Shares Surge After Securing Final Approval for AUD Drug Trial Site - MSN
Clearmind Medicine reports regaining Nasdaq equity compliance after financings - Investing.com India
Clearmind Medicine reports regaining Nasdaq equity compliance after financings By Investing.com - Investing.com Australia
Clearmind Medicine Inc. Receives Nasdaq Compliance Notice Regarding Minimum Bid Price Requirement - Quiver Quantitative
Clearmind Medicine stock drops after Nasdaq compliance notice By Investing.com - Investing.com South Africa
0.29%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):